Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free ADMA Stock Alerts

ADMA Biologics (ADMA) Short Interest Ratio & Short Volume

ADMA Biologics logo
$9.58 +0.07 (+0.74%)
As of 04:00 PM Eastern
Compare

ADMA Biologics Short Interest Overview

As of August 14, 2026, ADMA Biologics (ADMA) had a short interest of 22.68 million shares sold short, representing 10.54% of the public float. This marks a 3.49% increase in short interest since the prior report. The short interest ratio (days to cover) is 8.0, meaning it would take 8.0 days of the average trading volume of 4.35 million shares to cover all short positions.

Current Short Interest
22,683,647 shares
Previous Short Interest
21,918,195 shares
Change Vs. Previous Month
3.49%
Dollar Volume Sold Short
$214.81 million
Short Interest Ratio
8.0 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
223,990,000 shares
Short Percent of Float
10.54%
Today's Trading Volume
1,326,044 shares
Average Trading Volume
4,347,054 shares
Today's Volume Vs. Average
31%
Short Selling ADMA Biologics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for ADMA Biologics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ADMA Short Interest Over Time

ADMA Days to Cover Over Time

ADMA Percentage of Float Shorted Over Time

ADMA Biologics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/202622,683,647 shares $214.81 million +3.5%10.5%7.98 $9.47
7/31/202621,918,195 shares $185.43 million -8.8%9.8%8.83 $8.46
7/15/202624,031,512 shares $208.59 million -0.8%10.8%9.12 $8.68
6/30/202624,232,698 shares $202.83 million +13.9%10.9%5.81 $8.37
6/15/202621,280,060 shares $180.88 million +7.0%9.6%6.49 $8.50
5/29/202619,897,126 shares $158.78 million -0.5%8.9%6.03 $7.98
5/15/202619,994,416 shares $165.35 million -3.2%9.0%2.26 $8.27
4/30/202620,658,114 shares $211.75 million +7.0%9.0%3.22 $10.25
4/15/202619,306,519 shares $205.61 million -12.9%8.7%3.84 $10.65
3/31/202622,175,506 shares $199.80 million -14.1%10.0%1.64 $9.01
3/13/202625,826,838 shares $391.28 million +35.0%11.3%7.12 $15.15
2/27/202619,137,458 shares $297.97 million -9.1%8.6%5.72 $15.57
2/13/202621,049,574 shares $338.69 million +8.3%9.5%11.75 $16.09
1/30/202619,439,065 shares $336.30 million +4.7%8.5%9.19 $17.30
1/15/202618,573,160 shares $325.03 million -2.1%8.1%7.22 $17.50
12/31/202518,972,317 shares $346.06 million +0.8%8.3%9.32 $18.24
12/15/202518,829,424 shares $371.50 million +1.4%8.2%7.26 $19.73
11/28/202518,563,031 shares $366.25 million -0.4%8.1%5.87 $19.73
11/14/202518,629,225 shares $289.87 million +11.9%8.1%4 $15.56
10/31/202516,649,924 shares $257.74 million -5.2%7.2%5.55 $15.48
10/15/202517,560,000 shares $264.98 million +0.9%7.6%5.2 $15.09
9/30/202517,410,000 shares $255.23 million +10.6%N/A5.4 $14.66
9/15/202515,740,000 shares $240.82 million +5.1%N/A5 $15.30
8/31/202514,980,000 shares $258.55 million +0.1%6.5%4.6 $17.26
8/15/202514,960,000 shares $254.17 million +8.9%N/A5 $16.99
7/31/202513,740,000 shares $256.94 million -5.0%6.0%4.2 $18.70
7/15/202514,470,000 shares $260.17 million -10.9%N/A4.5 $17.98
6/30/202516,240,000 shares $295.73 million +17.6%7.0%4.6 $18.21
6/15/202513,810,000 shares $287.39 million -3.5%6.0%4 $20.81
5/31/202514,310,000 shares $285.77 million +7.4%6.3%4.1 $19.97
5/15/202513,330,000 shares $255.94 million +7.9%5.9%3.7 $19.20
4/30/202512,350,000 shares $293.93 million -6.9%N/A3.6 $23.80
4/15/202513,260,000 shares $293.71 million +2.3%5.8%4.4 $22.15
3/31/202512,960,000 shares $257.13 million -14.0%5.7%4.6 $19.84
3/15/202515,070,000 shares $277.74 million +5.9%6.6%5.6 $18.43
2/28/202514,230,000 shares $233.23 million +3.6%6.3%5.8 $16.39
2/15/202513,740,000 shares $218.47 million +4.3%6.0%5.8 $15.90
1/31/202513,180,000 shares $212.86 million -2.6%N/A4.9 $16.15
1/15/202513,530,000 shares $226.09 million -0.7%N/A4.6 $16.71
12/31/202413,620,000 shares $233.58 million +11.8%N/A3.9 $17.15
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
12/15/202412,180,000 shares $226.43 million -5.7%N/A3.2 $18.59
11/30/202412,910,000 shares $259.62 million -9.3%N/A2.6 $20.11
11/15/202414,240,000 shares $271.13 million -6.3%N/A2.8 $19.04
10/31/202415,200,000 shares $247.91 million -5.4%N/A2.9 $16.31
10/15/202416,070,000 shares $266.44 million -5.9%N/A3.1 $16.58
9/30/202417,080,000 shares $341.43 million +37.5%N/A3.6 $19.99
9/15/202412,420,000 shares $224.68 million +30.7%N/A2.6 $18.09
8/31/20249,500,000 shares $164.45 million +5.3%N/A2.6 $17.31
8/15/20249,020,000 shares $158.66 million +3.1%N/A2.6 $17.59
7/31/20248,750,000 shares $107.45 million +5.7%N/A2.5 $12.28
7/15/20248,280,000 shares $110.87 million +13.9%N/A2.6 $13.39
6/30/20247,270,000 shares $81.28 million -23.0%N/A2.5 $11.18
6/15/20249,440,000 shares $100.35 million +2.5%N/A3.4 $10.63
5/31/20249,210,000 shares $87.96 million +9.1%N/A3.3 $9.55
5/15/20248,440,000 shares $76.80 million -3.2%N/A2.9 $9.10
4/30/20248,720,000 shares $56.85 million +7.5%N/A3.4 $6.52
4/15/20248,110,000 shares $48.50 million +11.3%N/A3.2 $5.98
3/31/20247,290,000 shares $48.11 million -8.8%N/A2.7 $6.60
3/15/20247,990,000 shares $47.86 million +18.9%N/A3 $5.99
2/29/20246,720,000 shares $36.02 million +9.3%N/A2.6 $5.36
2/15/20246,150,000 shares $33.21 million -10.1%N/A2.9 $5.40
1/31/20246,840,000 shares $35.50 million -14.8%N/A3.2 $5.19
1/15/20248,030,000 shares $40.07 million +19.0%N/A3.7 $4.99
12/31/20236,750,000 shares $30.51 million -13.6%N/A3.4 $4.52
12/15/20237,810,000 shares $32.80 million -10.2%N/A4.2 $4.20
11/30/20238,700,000 shares $32.19 million -6.3%N/A4.9 $3.70
11/15/20239,280,000 shares $35.26 million -3.1%N/A4.8 $3.80
10/31/20239,580,000 shares $32.38 million +3.9%N/A4.1 $3.38
10/15/20239,220,000 shares $29.60 million +3.3%N/A4.2 $3.21
9/30/20238,930,000 shares $31.97 million +2.8%N/A4.1 $3.58
9/15/20238,690,000 shares $32.41 million -1.9%N/A4.1 $3.73
8/31/20238,860,000 shares $34.11 million -1.7%N/A4 $3.85
8/15/20239,010,000 shares $40.91 million +8.4%N/A4.2 $4.54
7/31/20238,310,000 shares $34.49 million -2.4%N/A4.1 $4.15
7/15/20238,510,000 shares $30.38 million +2.7%N/A4.2 $3.57
6/30/20238,290,000 shares $30.59 million -19.8%N/A3.9 $3.69
6/15/202310,340,000 shares $41.26 million -1.2%N/A4.6 $3.99
5/31/202310,460,000 shares $42.57 million -6.4%N/A4.4 $4.07
5/15/202311,170,000 shares $46.80 million -1.2%N/A4.6 $4.19
4/30/202311,310,000 shares $37.89 million -2.8%N/A5.1 $3.35
4/15/202311,640,000 shares $37.02 million -6.8%N/A4.9 $3.18
3/31/202312,490,000 shares $41.34 million +14.4%N/A5.1 $3.31
3/15/202310,920,000 shares $34.18 million +0.8%N/A4.4 $3.13
2/28/202310,830,000 shares $38.45 million -6.2%N/A3.8 $3.55
2/15/202311,550,000 shares $41.35 million -9.7%N/A3.9 $3.58
1/31/202312,790,000 shares $47.20 million +6.1%N/A3.8 $3.69
1/15/202312,050,000 shares $40.97 million -5.3%N/A3.7 $3.40
12/30/202212,720,000 shares $49.35 million +1.8%N/A4 $3.88
12/15/202212,500,000 shares $44.50 million -37.4%N/A3.7 $3.56
11/30/202219,980,000 shares $66.73 million -8.1%N/A6 $3.34
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
11/15/202221,740,000 shares $70.44 million -15.9%N/A7.2 $3.24
10/31/202225,860,000 shares $72.93 million +0.2%N/A9.1 $2.82
10/15/202225,820,000 shares $67.65 million -6.3%N/A9.5 $2.62
9/30/202227,560,000 shares $66.97 million +6.0%N/A10.4 $2.43
9/15/202225,990,000 shares $70.43 million -2.0%N/A9 $2.71
8/31/202226,520,000 shares $71.60 million -6.2%N/A9.8 $2.70
8/15/202228,270,000 shares $68.13 million -1.7%N/A10.7 $2.41
7/31/202228,760,000 shares $61.55 million +0.1%N/A11.1 $2.14
7/15/202228,730,000 shares $66.08 million +1.3%N/A10.2 $2.30
6/30/202228,360,000 shares $56.15 million +11.0%N/A9.8 $1.98
6/15/202225,540,000 shares $51.85 million +1.0%N/A8.1 $2.03
5/31/202225,300,000 shares $51.87 million +5.4%N/A9.3 $2.05
5/15/202224,010,000 shares $42.26 million +4.5%N/A9.2 $1.76
4/30/202222,980,000 shares $42.28 million +3.1%N/A9.1 $1.84
4/15/202222,300,000 shares $44.82 million +10.1%N/A9.3 $2.01
3/31/202220,250,000 shares $37.06 million +25.0%N/A8.8 $1.83
3/15/202216,200,000 shares $25.11 million +10.7%N/A8.2 $1.55
2/28/202214,640,000 shares $23.57 million +4.4%N/A7.4 $1.61
2/15/202214,020,000 shares $23.41 million +36.0%N/A7.2 $1.67
1/31/202210,310,000 shares $14.95 million +1.2%N/A4.6 $1.45
1/15/202210,190,000 shares $14.27 million -4.1%N/A4.5 $1.40
12/31/202110,620,000 shares $14.97 million +6.6%N/A4.1 $1.41
12/15/20219,960,000 shares $12.75 million -1.2%N/A4 $1.28
11/30/202110,080,000 shares $13.91 million -9.7%N/A4.1 $1.38
11/15/202111,160,000 shares $17.30 million -7.4%N/A3.5 $1.55
10/29/202112,050,000 shares $15.54 million +4.4%N/A3.5 $1.29
10/15/202111,540,000 shares $12.69 million +10.5%N/A3.5 $1.10
9/30/202110,440,000 shares $11.80 million -9.9%8.3%3.6 $1.13
9/15/202111,590,000 shares $13.91 million -5.2%9.2%3.7 $1.20

ADMA Short Interest - Frequently Asked Questions

Short interest is the volume of ADMA Biologics shares that have been sold short but have not yet been covered or closed out. As of August 14th, traders have sold 22,683,647 shares of ADMA short. 10.54% of ADMA Biologics' shares are currently sold short. Learn More on ADMA Biologics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADMA shares currently have a short interest ratio of 8.0. Learn More on ADMA Biologics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.54% of ADMA Biologics' floating shares are currently sold short.

ADMA Biologics saw a increase in short interest during the month of August. As of August 14th, there was short interest totaling 22,683,647 shares, an increase of 3.5% from the previous total of 21,918,195 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

10.54% of ADMA Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to ADMA Biologics: ACADIA Pharmaceuticals Inc. (7.45%), Allogene Therapeutics, Inc. (19.66%), TG Therapeutics, Inc. (21.59%), Alkermes plc (9.22%), Spyre Therapeutics, Inc. (15.86%), Rhythm Pharmaceuticals, Inc. (15.75%), Scholar Rock Holding Corporation (16.68%), CG Oncology, Inc. (13.33%), Mirum Pharmaceuticals, Inc. (10.90%), Erasca, Inc. (10.28%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling ADMA is an investing strategy that aims to generate trading profit from ADMA Biologics as its price is falling. ADMA shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ADMA Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADMA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADMA, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ADMA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:ADMA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel